Crinone Gel
Product Images NDC 0023-6151
Product Visual Gallery
This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Crinone (NDC 0023-6151). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Allergan, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure A (Crinone 02)
Figure B (Crinone 03)
Figure C (Crinone 04)
Figure D And Figure E (Crinone 05)
Figure F (Crinone 06)
Figure G (Crinone 07)
Figure H (Crinone 08)
Principal Display Panel Ndc 0023-6150-04crinone®(progesterone Gel) 4%- 6 Single-use Prefilled Applicatorseach Applicator Contains 1.3 G Of Gel And Delivers1.125 G Of Gel Containing 45 mg Progesterone.- For Vaginal Use Only- Rx Onlyabbvie (Crinone 09)
Principal Display Panel Ndc 0023-6151-08crinone®(progesterone Gel) 8%- 15 Single-use Prefilled Applicatorseach Applicator Contains 1.3 G Of Gel And Delivers1.125 G Of Gel Containing 90 mg Progesterone.- For Vaginal Use Only- Rx Onlyabbvie (Crinone 0a)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.